Canaccord Genuity Reiterates Buy on MDA, Maintains C$14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Doug Taylor has reiterated a 'Buy' rating on MDA (TSX:MDA) and maintained a price target of C$14.
September 01, 2023 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Doug Taylor has reiterated a 'Buy' rating on MDA, maintaining a price target of C$14.
The reiteration of a 'Buy' rating by Canaccord Genuity indicates a positive outlook for MDA. The maintained price target of C$14 suggests that the analyst believes the stock has potential for growth. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100